Shenzhen Beimei Pharmaceutical Co.

PharmaceuticalsSeries BShenzhen, Chinabeimeiyaoye.com

Latest round

Series B

Last raised

Apr 2022

Total raised

$16M

Investors

4

About Shenzhen Beimei Pharmaceutical Co.

, Ltd. is a pharmaceutical company that focuses on children's prescription drugs. It has set up a professional research and development and overseas product introduction team. The company has also partnered with top 5 Indian pharmaceutical companies such as Cipla, Hetero, and European pharmaceutical companies such as DEVA Holding, EMP Pharma, LTS, MedPharma, for more than 10 pediatric drugs. In December 2022, its product, DENOSIN Oral Solution obtained the production licence B certification. In June 2023, it established its production base in Jiangsu., Ltd. The company's pharmaceutical products are used in the respiratory, neurological, anti-infective, dermatological, hematology, gastroenterology, immunological and endocrinology. Representative drugs include oseltamivir phosphate for suspension, lacosamide Oral Solution, atomoxetine hydrochloride oral solution, sultamicillin for suspension, and oseltamivir phosphate for oral suspension.

Who invested in Shenzhen Beimei Pharmaceutical Co.

4 investors across 1 round

See all investors in Shenzhen Beimei Pharmaceutical Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Apr 6, 2022

    Amount

    $16M

    Investors

    Locked

Questions about Shenzhen Beimei Pharmaceutical Co.

Who invested in Shenzhen Beimei Pharmaceutical Co.?

Shenzhen Beimei Pharmaceutical Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Shenzhen Beimei Pharmaceutical Co. raised?

Shenzhen Beimei Pharmaceutical Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Shenzhen Beimei Pharmaceutical Co. last raise money?

Shenzhen Beimei Pharmaceutical Co.'s most recent round on record is a Series B, in Apr 2022.

What does Shenzhen Beimei Pharmaceutical Co. do?

Shenzhen Beimei Pharmaceutical Co. is a pharmaceuticals company.

Where is Shenzhen Beimei Pharmaceutical Co. headquartered?

Shenzhen Beimei Pharmaceutical Co. is headquartered in Shenzhen, China.

Which VCs invest in companies like Shenzhen Beimei Pharmaceutical Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Shenzhen Beimei Pharmaceutical Co.'s stage. Their profiles are linked below.

Raising like Shenzhen Beimei Pharmaceutical Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.